Stress and its control in cancer patients. Loss of appetite and cachexia--nausea and vomiting
Decker-Baumann, C.
Pflege Zeitschrift 50(8) Suppl: 8-10
1997
ISSN/ISBN: 0945-1129 PMID: 9290341 Document Number: 482530
Document emailed within 1 workday
Related Documents
Dolgin, M.J.; Katz, E.R.; McGinty, K.; Siegel, S.E. 1985: Anticipatory nausea and vomiting in pediatric cancer patients Pediatrics 75(3): 547-552Johnson, M.H.; Moroney, C.E.; Gay, C.F. 1997: Relieving nausea and vomiting in patients with cancer: a treatment algorithm Oncology Nursing Forum 24(1): 51-57
Aapro, M.S. 1981: Prevention of chemotherapy-induced nausea and vomiting in patients with cancer Arizona Medicine 38(11): 843-845
Selen, D.J.; Gilbert, M.P. 2017: Nausea/vomiting · tachycardia · unintentional weight loss · Dx? Journal of Family Practice 66(2): E1-E2
Shelke, A.R.; Mustian, K.M.; Morrow, G.R. 2004: The pathophysiology of treatment-related nausea and vomiting in cancer patients: current models Indian Journal of Physiology and Pharmacology 48(3): 256-268
Keats, S. 2010: High-dose rate brachytherapy in prostate cancer patients--a study on nausea and vomiting Urologic Nursing 30(3): 195-202
Kawashita, Y.; Shimada, M.; Utsunomiya, T.; Imura, S.; Morine, Y.; Ikemoto, T.; Mori, H.; Hanaoka, J. 2011: Aprepitant successful for controlling nausea and vomiting in a case having difficulty with control treatment in a standard antienemic therapy involving chemotherapy for gallbladder cancer postoperative recurrence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 861-864
Han, Y.-s.; Zhuang, Q.-l.; Wu, G.-h. 2012: Proteolysis induce factor in the digestive systematic cancer cachexia patients: its expression and role in cancer cachexia Zhonghua Wei Chang Wai Ke Za Zhi 15(12): 1287-1290
Rabasseda, X. 2002: Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting Drugs of Today 38(2): 75-89
Rabbani, M.Z.; Khan, M.N.A.; Qureshi, R.; Zubair, M.; Pervez, M.B. 2010: Does the added benefit of ondansetron over dexamethasone, to control post-operative nausea and vomiting, justify the added cost in patients undergoing tonsillectomy and adenotonsillectomy? JPMA. Journal of the Pakistan Medical Association 60(7): 559-561
Bethea, R.C. 1960: Evaluation of a combination of meclizine and pyridoxine in the control of nausea and vomiting in pregnancy International Record of Medicine 173: 283-287
Aoyama, N.; Asano, S.; Shingu, M.; Ueno, K.; Miyashita, M.; Hamada, H.; Aikata, H.; Kataoka, T. 2015: Changes in Appetite, Nutrition, and Oxidative Stress Reaction of Cancer Patients during Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 961-965
Takatsuki, K.; Kado, T.; Satouchi, M.; Nakajima, T.; Nagai, K.; Ohsugi, F.; Yanagida, E.; Minegaki, A. 1998: Psychiatric studies of chemotherapy and chemotherapy-induced nausea and vomiting of patients with lung or thymic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 403-408
Morrow, G.R.; Roscoe, J.A.; Hickok, J.T.; Stern, R.M.; Pierce, H.I.; King, D.B.; Banerjee, T.K.; Weiden, P. 1998: Initial control of chemotherapy-induced nausea and vomiting in patient quality of life Oncology 12(3 Suppl 4: 32-37
1980: Marihuana for nausea and vomiting due to cancer chemotherapy Medical Letter on Drugs and Therapeutics 22(10): 41-43
Duigon, A. 1986: Anticipatory nausea and vomiting associated with cancer chemotherapy Oncology Nursing Forum 13(1): 35-40
Sone, A.; Makishima, K.; Oouchi, H.; Nigou, N.; Motomura, H.; Murakami, M. 2010: Special diet for cancer patients with the chemotherapy-induced appetite loss improves the quality of life in palliative care Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(11): 2217-2220
Pacetti, U.; Veltri, E.; Fattoruso, S.Ileana.Sara.; Cardillo, F.D'Assisi.; Evangelista, S.; Cognetti, F.; Fabi, A. 2013: Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancer Anticancer Research 33(4): 1721-1724
Taguchi, T.; Tsukamoto, F.; Watanabe, T.; Yoneda, K.; Takamura, Y.; Hojo, S.; Shiba, E.; Noguchi, S. 1999: Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(8): 1163-1170
Heeney, E. 2005: Improving care for patients with nausea and vomiting Nursing Times 101(14): 33